Effect of antithrombin III on neutrophil deformability

Journal of Leukocyte Biology

Volumn 78, Issue 3, 2005, Pages 777-784

  Saito, Hajime ^a   Minamiya, Yoshihiro ^a   Kalina, Uwe ^b   Saito, Satoshi ^a   Ogawa, Jun Ichi ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ZLB Behring   (Germany)

Author keywords

F actin; fMLP; Stiffness

Indexed keywords

ANTITHROMBIN III; BOVINE SERUM ALBUMIN; ENDOTOXIN; F ACTIN; FLUORESCEIN ISOTHIOCYANATE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HEPARIN; HEPARIN LYASE; PHALLOIDIN; PROTEOGLYCAN; SYNDECAN 4;

ACTIN POLYMERIZATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LABELING; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LUNG CAPILLARY; NEUTROPHIL; PRIORITY JOURNAL; RIGIDITY; SEPSIS;

ACTINS; ANTITHROMBIN III; HEPARIN LYASE; HUMANS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PHALLOIDINE; REFERENCE VALUES; STAINING AND LABELING;

EID: 24744441485     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1004589     Document Type: Article

References (39)

1. Worthen, G. S., Schwab III, B., Elson, E. L., Downey, G. P. (1989) Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. Science 245, 183-186.
2. Doerschuk, C. M., Allard, M. F., Hogg, J. C. (1989) Neutrophil kinetics in rabbits during infusion of zymosan-activated plasma. J. Appl. Physiol. 67, 88-95.
3. Motosugi, H., Graham, L., Noblitt, T. W., Doyle, N. A., Quinlan, W. M., Li, Y., Doerschuk, C. M. (1996) Changes in neutrophil actin and shape during sequestration induced by complement fragments in rabbits. Am. J. Pathol. 149, 963-973.
4. Frank, R. S. (1990) Time-dependent alternations in the deformability of human neutrophils in response to chemotactic activation. Blood 76, 2606-2612.
5. Downey, G. P., Elson, E. L., Schwab III, B., Erzurum, S. C., Young, S. K., Worthen, G. S. (1991) Biophysical properties and microfilament assembly in neutrophils: modulation by cyclic AMP. J. Cell Biol. 114, 1179-1190.
6. Saito, H., Wang, Q., Doerschuk, C. M. (1998) Mechanical properties of rat neutrophils in response to inflammatory stimuli. Am. J. Respir. Crit. Care Med. 157, A35.
7. Saito, H., Lai, J., Rogers, R., Doerschuk, C. M. (2002) Mechanical properties of rat bone marrow and circulating neutrophils and their responses to inflammatory mediators. Blood 99, 2207-2213.
8. Bauer, K. A., Rosenberg, R. D. (1991) Role of antithrombin III as a regulator of in vivo coagulation. Semin. Hematol. 28, 10-18.
9. Eisele, B., Lamy, M., Thijs, L. G., Keinecke, H. O., Schuster, H. P., Matthias, F. R., Fourrier, F., Heinrichs, H., Delvos, U. (1998) Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis. Intensive Care Med. 24, 663-672.
10. Mizutani, A., Okajima, K., Uchiba, M., Isobe, H., Harada, N., Mizutani, S., Noguchi, T. (2003) Antithrombin reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation through promotion of prostacyclin production. Blood 101, 3029-3036.
11. Dunzendorfer, S., Kaneider, N., Rabensteiner, A., Meierhofer, C., Reinisch, C., Romisch, J., Wiedermann, C. J. (2001) Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III. Blood 97, 1079-1085.
12. Oelschlager, C., Romisch, J., Staubitz, A., Stauss, H., Leithauser, B., Tillmanns, H., Holschermann, H. (2002) Antithrombin III inhibits nuclear factor κB activation in human monocytes and vascular endothelial cells. Blood 99, 4015-4020.
13. O'Reilly, M. S., Pirie-Shepherd, S., Lane, W. S., Folkman, J. (1999) Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science 285, 1926-1928.
14. Inano, H., English, D., Doerschuk, C. M. (1992) Effect of zymosan-activated plasma on the deformability of rabbit polymorphonuclear leukocytes. J. Appl. Physiol. 73, 1370-1376.
15. Higson, F. K., Kikuchi, Y., Jones, O. T. G., Hughes, M. (1983) Effect of respiratory-burst stimuli on the flow properties of pig blood neutrophils. J. Cell Sci. 64, 323-330.
16. Nash, G. B., Jones, J. G., Mikita, J., Dormandy, J. A. (1988) Methods and theory for analysis of flow of white cell subpopulations through micropore filters. Br. J. Haematol. 70, 165-170.
17. Nash, G. B., Jones, J. G., Mikita, J., Christopher, B., Dormandy, J. A. (1988) Effect of preparative procedures and of cell activation on flow of white cells through micropore filters. Br. J. Haematol. 70, 171-176.
18. Tanner, L. M., Scott, R. B. (1976) A filtration model for the study of leukocyte transit in the microcirculation. Am J Hematol 1, 293-305.
19. Gallagher, J. T. (1994) Heparan sulfates as membrane receptors for the fibroblast growth factors. Eur. J. Clin. Chem. Clin. Biochem. 32, 239-247.
20. Uchiba, M., Okajima, K., Murakami, K., Okabe, H., Takatsuki, K. (1996) Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin III. Am. J. Physiol. 270, L921-L930.
21. Isobe, H., Okajima, K., Uchiba, M., Harada, N., Okabe, H. (2002) Antithrombin prevents endotoxin-induced hypotension by inhibiting the induction of nitric oxide synthase in rats. Blood 99, 1638-1645.
22. Roemisch, J., Gray, E., Hoffmann, J. N., Wiedermann, C. J. (2002) Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coagul. Fibrinolysis 13, 657-670.
23. Fourrier, F., Jourdain, M., Tournoys, A. (2000) Clinical trial results with antithrombin III in sepsis. Crit. Care Med. 28, S38-S43.
24. Kubo, H., Doyle, N. A., Graham, L., Bhagwan, S. D., Quinlan, W. M., Doerschuk, C. M. (1999) L- and P-selectin and CD11/CD18 in intracapillary neutrophil sequestration in rabbit lungs. Am. J. Respir. Crit. Care Med. 159, 267-274.
25. Doerschuk, C. M. (1999) Neutrophil rheology and transit through capillaries and sinusoids. Am. J. Respir. Crit. Care Med. 159, 1693-1695.
26. Doerschuk, C. M., Mizgerd, J. P., Kubo, H., Qin, L., Kumasaka, T. (1999) Adhesion molecules and cellular biomechanical changes in acute lung injury. Chest 116, 37S-43S.
27. Minamiya, Y., Saito, S., Kalina, U., Saito, H., Terada, K., Ogawa, J. (2004) Antithrombin III diminishes production of oxygen radical in endotoxin-infused rat lung. Shock 21, 139-143.
28. Huber, R., Carrell, R. W. (1989) Implications of the three-dimensional structure of α 1-antitrypsin for structure and function of serpins. Biochemistry 28, 8951-8966.
29. Nishioka, J., Suzuki, K. (1992) The role of the COOH-terminal region of antithrombin III. Evidence that the COOH-terminal region of the inhibitor enhances the reactivity of thrombin and factor Xa with the inhibitor. J. Biol. Chem. 267, 22224-22229.
30. Horie, S., Ishii, H., Kazama, M. (1990) Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not for thrombin-dependent prostacyclin production in human endothelial cells. Thromb. Res. 59, 895-904.
31. Yamauchi, T., Umeda, F., Inoguchi, T., Nawata, H. (1989) Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochem. Biophys. Res. Commun. 163, 1404-1411.
32. Larsson, H., Sjoblom, T., Dixelius, J., Ostman, A., Ylinenjarvi, K., Bjork, I., Claesson-Welsh, L. (2000) Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells. Cancer Res. 60, 6723-6729.
33. Woods, A., Couchman, J. R. (2001) Syndecan-4 and focal adhesion function. Curr. Opin. Cell Biol. 13, 578-583.
34. Saoncella, S., Echtermeyer, F., Denhez, F., Nowlen, J. K., Mosher, D. F., Robinson, S. D., Hynes, R. O., Goetinck, P. F. (1999) Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers. Proc. Natl. Acad. Sci. USA 96, 2805-2810.
35. Olson, S. T., Bjork, I., Sheffer, R., Craig, P. A., Shore, J. D., Choay, J. (1992) Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. J. Biol. Chem. 267, 12528-12538.
36. Kaneider, N. C., Egger, P., Dunzendorfer, S., Wiedermann, C. J. (2001) Syndecan-4 as antithrombin receptor of human neutrophils. Biochem. Biophys. Res. Commun. 287, 42-46.
37. Kaneider, N. C., Reinisch, C. M., Dunzendorfer, S., Romisch, J., Wiedermann, C. J., Wiederman, C. J. (2002) Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes. J. Cell Sci. 115, 227-236.
38. Oh, E. S., Woods, A., Couchman, J. R. (1997) Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C. J. Biol. Chem. 272, 8133-8136.
39. Couchman, J. R., Vogt, S., Lim, S. T., Lim, Y., Oh, E. S., Prestwich, G. D., Theibert, A., Lee, W., Woods, A. (2002) Regulation of inositol phospholipid binding and signaling through syndecan-4. J. Biol. Chem. 277, 49296-49303.